Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study. [electronic resource] by
- Doecke, J D
- Hartnell, F
- Bampton, P
- Bell, S
- Mahy, G
- Grover, Z
- Lewindon, P
- Jones, L V
- Sewell, K
- Krishnaprasad, K
- Prosser, R
- Marr, D
- Fischer, J
- R Thomas, G
- Tehan, J V
- Ding, N S
- Cooke, S E
- Moss, K
- Sechi, A
- De Cruz, P
- Grafton, R
- Connor, S J
- Lawrance, I C
- Gearry, R B
- Andrews, J M
- Radford-Smith, G L
Producer: 20170612
In:
Alimentary pharmacology & therapeutics vol. 45
Availability: No items available.
|